File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A systematic review of quality of thyroid-specific health-related quality of life instruments recommends ThyPRO for patients with benign thyroid diseases

TitleA systematic review of quality of thyroid-specific health-related quality of life instruments recommends ThyPRO for patients with benign thyroid diseases
Authors
Issue Date2016
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jclinepi
Citation
Journal of Clinical Epidemiology, 2016, v. 78, p. 63-72 How to Cite?
AbstractObjective: To appraise the measurement properties of thyroid-specific health-related quality of life (HRQOL) instruments, and to provide recommendations on the choice of HRQOL instruments. Study Design and Setting: Systematic review of English-language literature published between 1993 and 2015 identified psychometric studies involving patients with thyroid disease through a search of Pubmed, Web of Science, Embase, and OVID Medline. HRQOL instruments were graded on methodological quality and overall levels of evidence using a COSMIN checklist. Results: After a review of 743 original studies, 23 studies reporting 14 standardized HRQOL instruments targeted for Graves’ ophthalmopathy (n=4), hypothyroidism (n=3), thyroid cancer (n=2), other thyroid disease (n=3) and non-thyroid tumor sites (n=2) were identified. Hypothesis testing was evaluated most frequently. The 84-item thyroid-specific patient-reported outcome measure (ThyPRO) and 16-item Graves' ophthalmopathy specific Quality of Life (GO-QOL) instruments were the most extensively evaluated instrument. The highest number of positive ratings in overall level of psychometric evidence was found in ThyPRO, GO-QOL and 11-item Thyroid Treatment Satisfaction Questionnaire (ThyTSQ) instruments. Conclusions: The ThyPRO is recommended for the assessment of HRQOL in patients with benign thyroid diseases whilst measurement properties of GO-QOL and ThyTSQ are satisfactory in measuring HRQOL of patients with Graves’ ophthalmopathy and hypothyroidism, respectively.
Persistent Identifierhttp://hdl.handle.net/10722/224889
ISSN
2015 Impact Factor: 4.703
2015 SCImago Journal Rankings: 2.559

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorLang, HHB-
dc.contributor.authorLam, CLK-
dc.date.accessioned2016-04-18T03:33:49Z-
dc.date.available2016-04-18T03:33:49Z-
dc.date.issued2016-
dc.identifier.citationJournal of Clinical Epidemiology, 2016, v. 78, p. 63-72-
dc.identifier.issn0895-4356-
dc.identifier.urihttp://hdl.handle.net/10722/224889-
dc.description.abstractObjective: To appraise the measurement properties of thyroid-specific health-related quality of life (HRQOL) instruments, and to provide recommendations on the choice of HRQOL instruments. Study Design and Setting: Systematic review of English-language literature published between 1993 and 2015 identified psychometric studies involving patients with thyroid disease through a search of Pubmed, Web of Science, Embase, and OVID Medline. HRQOL instruments were graded on methodological quality and overall levels of evidence using a COSMIN checklist. Results: After a review of 743 original studies, 23 studies reporting 14 standardized HRQOL instruments targeted for Graves’ ophthalmopathy (n=4), hypothyroidism (n=3), thyroid cancer (n=2), other thyroid disease (n=3) and non-thyroid tumor sites (n=2) were identified. Hypothesis testing was evaluated most frequently. The 84-item thyroid-specific patient-reported outcome measure (ThyPRO) and 16-item Graves' ophthalmopathy specific Quality of Life (GO-QOL) instruments were the most extensively evaluated instrument. The highest number of positive ratings in overall level of psychometric evidence was found in ThyPRO, GO-QOL and 11-item Thyroid Treatment Satisfaction Questionnaire (ThyTSQ) instruments. Conclusions: The ThyPRO is recommended for the assessment of HRQOL in patients with benign thyroid diseases whilst measurement properties of GO-QOL and ThyTSQ are satisfactory in measuring HRQOL of patients with Graves’ ophthalmopathy and hypothyroidism, respectively.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jclinepi-
dc.relation.ispartofJournal of Clinical Epidemiology-
dc.titleA systematic review of quality of thyroid-specific health-related quality of life instruments recommends ThyPRO for patients with benign thyroid diseases-
dc.typeArticle-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailLang, HHB: blang@hkucc.hku.hk-
dc.identifier.emailLam, CLK: clklam@hku.hk-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityLang, HHB=rp01828-
dc.identifier.authorityLam, CLK=rp00350-
dc.identifier.doi10.1016/j.jclinepi.2016.03.006-
dc.identifier.pmid27020087-
dc.identifier.hkuros257486-
dc.identifier.volume78-
dc.identifier.spage63-
dc.identifier.epage72-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats